Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
glp-1 drugs for obesity Agonists Weight Loss Market Report, 2025-2030 GLP-1 Agonists: Using Semaglutide, Quantity:Triple-Pack ($99) Shop All Logic
GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity
Currently, liraglutide, semaglutide, and tirzepatide are FDA-approved for obesity treatment, while other agents are used off-label
Shop All Logic
Quantity:Triple-Pack ($99)
While all GLP-1 receptor agonists effectively lower hemoglobin A1c and promote weight loss, there are meaningful differences in their magnitude of effect, titration schedules, and adverse effect profiles that influence clinical decision-making
US$ 23.37
US$ 22.81
US$ 29.09
US$ 21.66
US$ 20.01
US$ 28.15
US$ 27.22
US$ 26.42
US$ 22.97
